findmyKOL
Clinical trialNCT03180307CompletedPhase 3Interventional

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

SponsorOn Target Laboratories, LLCEnrollment140Ovarian Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase 3, randomized, multi-center, single dose, open label, pivotal study in patients diagnosed with, or with high clinical suspicion of, ovarian cancer scheduled to undergo primary surgical cytoreduction, interval debulking, or recurrent ovarian cancer surgery.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Netherlands
  • Leiden University Medical Center

    Leiden, South Holland, Netherlands

United States
  • the Mayo Clinic - Phoenix

    Phoenix, Arizona, United States

  • University of Arizona

    Tucson, Arizona, United States

  • City of Hope Medical Center

    Duarte, California, United States

  • University of Ca at Irvine Chao Cancer Center

    Orange, California, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Karmanos Cancer Institutes

    Detroit, Michigan, United States

  • Mayo Clinic-Rochester

    Rochester, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Kettering Medical Center

    Kettering, Ohio, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

OTL38
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jan 2018
Primary completion
16 Apr 2020
Completion
16 Oct 2020
Last update posted
4 Feb 2022
Registered enrollment
140
Registry id
NCT03180307
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.